Company Analysis

Kyntra Bio, Inc. (KYNB)

Nasdaq: KYNB · Pharmaceutical Preparations · San Francisco, CA · filing with the SEC since 2002
Grade4.2
◀ Past 4.6● Present 4.1▶ Future 4.0
1 est.

Filings

328 filings since 2017 beside 591 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 44 days after the quarter ended. The proxy statement was last filed Apr 27, 2026.

Filings a yearinsider forms included
131907873107665135
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest Oct 6, 2026.Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Oct 1, 2026.SEC letters: 2 in the last 36 months, the newest Jul 9, 2024.
Insider forms 591

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Oct 6, 2026 8-K item 3.01 Listing warning from its exchange · Current report Sep 30, 2026
Oct 1, 2026 8-K item 5.02 Officer or director change · Current report Sep 30, 2026
Aug 31, 2026 8-K items 1.01, 2.03, 7.01, 9.01 Major agreement signed; New debt or obligation taken on; Investor disclosure (Regulation FD) · Current report
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Jun 16, 2026 8-K item 5.07 Shareholder vote · Current report Jun 12, 2026
Jun 9, 2026 8-K item 8.01 Other event · Current report Jun 2, 2026
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 12, 2026 10-Q Quarterly report Mar 31, 2026
May 11, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 27, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 27, 2026 DEFA14A Extra proxy material
Apr 27, 2026 DEF 14A Proxy statement Jun 12, 2026
Apr 9, 2026 8-K item 3.01 Listing warning from its exchange · Current report Apr 2, 2026
Mar 16, 2026 10-K Annual report Dec 31, 2025
Mar 16, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 7, 2026 8-K items 5.03, 8.01, 9.01 Charter, bylaw or fiscal-year change; Other event · Current report
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 10, 2025 10-Q Quarterly report Sep 30, 2025
Nov 10, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 6, 2025 8-K item 8.01 Other event · Current report
Sep 5, 2025 8-K items 2.01, 9.01 Purchase or sale of a business completed · Current report Aug 29, 2025
Sep 2, 2025 8-K items 8.01, 9.01 Other event · Current report Aug 29, 2025
Aug 18, 2025 8-K items 8.01, 9.01 Other event · Current report
Aug 15, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 14, 2025 8-K items 1.01, 9.01 Major agreement signed · Current report Aug 12, 2025
Aug 11, 2025 10-Q Quarterly report Jun 30, 2025
Aug 11, 2025 8-K items 2.02, 9.01 Results released · Current report
Jul 29, 2025 SCHEDULE 13G/A Large holder update, amended
Jul 14, 2025 8-K items 1.01, 9.01 Major agreement signed · Current report
Jun 13, 2025 8-K item 1.02 Major agreement ended · Current report Jun 12, 2025
Jun 12, 2025 8-K items 3.03, 5.03, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report Jun 10, 2025
Jun 9, 2025 8-K items 1.01, 5.02, 5.07, 9.01 Major agreement signed; Officer or director change; Shareholder vote · Current report Jun 4, 2025
May 15, 2025 SCHEDULE 13G/A Large holder update, amended
May 12, 2025 10-Q Quarterly report Mar 31, 2025
May 12, 2025 8-K items 2.02, 9.01 Results released · Current report
Apr 25, 2025 ARS Annual report to shareholders Dec 31, 2024
Apr 25, 2025 DEFA14A Extra proxy material
40 of 328 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton KYNB · research, not advice